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Abstract 
Background: One of the objectives of a smooth laryngoscopy is to minimize 
hemodynamic changes. The goal of this study was to assess the effects of 
dexmedetomidine and labetalol on heart rate and blood pressure changes after 
laryngoscopy compared to a control group.  
Materials and Methods: This was a double-blind clinical trial conducted on 
120 patients aged between 18 and 60 years, who were candidates for surgery, 
under general anesthesia, at Alzahra hospital in Isfahan during 2017-2018. 
Patients were randomly allocated to three groups of being administered 
dexmedetomidine or labetalol and a control group. The patient's age, weight, 
height, gender and clinical data including mean blood pressure (BP), heart rate, 
systolic BP, diastolic BP and oxygen saturation during 1, 3, 5 and 10 minutes 
after intubation were collected and analyzed using repeated measure analysis.  
Results: The average age of patients who were candidates for surgery was 
42.62 +/- 1.40. 52 percent (63 patients) were male subjects. The results 
showed no significant difference in mean BP, diastolic BP, systolic BP or 
oxygen saturation (p>0.05) in the three groups. But the difference in heart 
rate between the three groups was statistically significant. The heart rate in 
the dexmedetomidine group was significantly lower than the labetalol and 
control groups (p=0.00).  
Conclusion: Results of the current study showed that using labetalol provided 
desirable hemodynamic stability compared to dexmedetomidine and caused 
less hemodynamic disturbances.  
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Introduction 
Laryngoscopy and tracheal intubation during 
anesthesia increase the release of catechol amines 
along with sympathetic stimulation, resulting in 
increased blood pressure, heart rate, and arrhythmias, 
which can lead to dangerous conditions such as 
myocardial ischemia in patients with risk factors such 
as increased blood pressure and ischemic heart 
diseases (1-4). Various pharmacological drugs 
(opioids, lidocaine, beta-adrenergic antagonists and 
vasodilators) have been prescribed for suppressing 
sympathetic adrenal stimulation and hemodynamic 
changes before laryngoscopy and tracheal intubation; 
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however, none of such drugs were able to suppress 
hemodynamic responses without adverse effects (5). 
Dexmedetomidine is an alpha 2 agonist that is 
highly selective for alpha 2 receptor (6) and is more 
inclined to alpha-2 receptor as opposed to clonidine 
(dexmedetomidine 1600/1 a2 / a1) and (clonidine a1 / 
200 a1) (6). Dexmedetomidine activates the alpha2 
adrenergic receptors and alleviates the patient and 
inserts the person in the second stage of non REM sleep 
and helps with postoperative recovery (6). Activating 
the alpha2 receptors inhibits the sympathetic center. 
This causes bladder hypotension and bradycardia, and 
the hemodynamic stability of the patient during 
surgery and reduces the need for opioid (1). Anxiolytic, 
relaxant and hypotensive effects are induced by 
stimulation of the central receptors a2a and 
imidazoline type1A1 (2). In two studies performed on 
140 children aged 1-7 years, it was revealed that 
dexmedetomidine had a more sedative effect than 
midazolam or propofol (10). Labetalol is a receptor B 
antagonist, which also has antagonistic properties of 
alpha receptors (9), Labetalol and Esmolol both 
decrease systolic and diastolic blood pressure (10). 
Esmolol reduces heart rate, sometimes causing 
bradycardia, whereas Labetalol causes a decrease in 
average heart rate (10). Compared to Esmolol, 
Labetalol does not cause orthostatic hypotension and 
does not bring about serious complications such as 
tachycardia and bradycardia, and is more cost effective 
too (10). Labetalol may be an economically viable 
alternative to Esmolol, especially in elderly patients 
where the risk of unwanted hypotension is lower (10). 
Although hemodynamic impairment during operation 
is usually managed by increasing the concentration of 
anesthetic or opioid or both, it is more appropriate to 
use cardiovascular medicines to treat such disorders. 
Using Esmolol infusion instead of alfentanil to control 
heart rate reduces emergency problems after 
arthroscopy (11). In 1984, Cormack and Lehane 
described the grading system for laryngoscopic sights. 
In this system, in Grade 1, all laryngeal openings can 
be seen. In Grade 2, only the back side of the laryngeal 
openings can be seen. Furthermore, in Grade 3, only 
epiglottis is observed, and in Grade 4, no epiglottis nor 
larynx are seen (12). In various studies, the effect of 
dexmedetomidine or labetalol on hemodynamic 
changes alone has been studied; however, studies that 
compare these two drugs with one another with the 
control group are limited. Accordingly, we conducted 
a study that aimed to compare the effect of these two 
drugs on hemodynamic changes induced by anesthetic 
laryngoscopy. 
Methods 
This study was a randomized, prospective, 
double blind, clinical trial. Obtaining permission from 
the Ethics Committee of Isfahan University of Medical 
Sciences (IR.MUI.MED.REC.1396.3.917) and written 
informed consent from patients. The study was 
registered in the Iranian clinical trial registry, coded 
IRCT20160812029310N3. A total of 120 male and 
female ASA I and II patients in the range of 18 to 60 
years old who were candidates for surgery under 
general anesthesia in Alzahra hospital. They were 
randomly divided into three groups during the years of 
2017 and 18. With regard to the formula for the 
comparison of the means, the sample size was at least 
36 in each group, due to the probability of a 10% drop 
in the sample from the beginning, 40 people were 
selected in each group. 
Inclusion criteria: All patients undergoing elective 
surgery at al-Zahra Hospital, aged between 18 and 60 
years old under general anesthesia, were physically 
examined and were diagnosed with ASA I and II. None 
of them had alcohol and drug addiction. 
Non-inclusion criteria: history of sensitivity, grade 3 
cardiopulmonary block, asthma, heart failure, history 
of heart attacks in the last six months, IHD, TCA use, 
MAOI, fever, obesity (BMI greater than 27), 
neurological diseases, and respiratory diseases. 
Exclusion criteria: Laryngoscopy lasts longer than 30 
seconds, laryngoscopy more than once tried, and 
cardiopulmonary arrest.  
Random collection sampling technique was 
used to randomly place the patients in three groups. 
Fluid therapy protocol at NPO time was the same in all 
patients and in accordance with the law 4-2-1 and 
according to law 6 -8-10 during the operation without 
heating the fluids. After placement of patients on the 
operating bed, after connecting standard monitoring, 
including pulse oximeter, capnography and ECG, the 
vital signs were recorded in three groups, and the drugs 
were first introduced as blouse and then infusion. In 
group A, 0.1 μg / kg of dexmedetomidine was given as 
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blouse (7) and 0.1 μg in infusion for 10 minutes, and in 
group B, 0.1 mg/kg Labetalol in blouse and 0.1 mg in 
infusion for 10 minutes and in group C, normal saline 
was given in the same volume and form with two 
previous medications. Three minutes after 
administration of muscle relaxant, laryngoscopy and 
tracheal intubation were performed and the vital signs 
were recorded in 1, 3, 5, and 10 minutes later. All drugs 
were injected into the same form and volume into a 
single-syringe and injected to a patient in a blinded 
manner. After conducting intubation and ensuring its 
correct location, anesthesia was continued with 
isoflurane at MAC level and NO2 60% in O2 and 0.1 
mg/kg morphine. The mean arterial blood pressure 
(MAP), heart rate (HR), systolic blood pressure (SBP) 
and diastolic blood pressure (DBP) were recorded at 3, 
5, 5, 10 minutes after intubation and then at 60 and 120 
after induction of anesthesia in three groups. The 
patient's ventilation was maintained in such a way that 
ETCO2 was maintained at about 30-35. 
At the end of surgery, muscle relaxant, using 
atropine 0.02 mg/kg and neostigmine 0.04 mg/kg, and 
after complete awakening, the patient was extubated 
and transferred to recovery. During the extubation time 
(from the time the anesthetic gas was abated until 
extubation), duration of anesthesia, surgery and 
recovery, and duration of waking from anesthesia 
(from extubation to patient response to time, place, and 
person) were recorded. After the patient was entered 
into the recovery room, the patient was continuously 
administered oxygen through a nasal catheter at a rate 
of 3 liters per minute and then covered with a blanket. 
Patient information including height, weight, 
age, gender and clinical symptoms were recorded in a 
checklist made by the registrar and entered into the 
SPSS software version 22. Statistical analyses were 
provided in descriptive and analytical sections. To 
analyze the data, descriptive statistics including 
frequency tables and central indices and dispersion 
were used to describe the most important 
characteristics of the subjects. Repeated measure test 
was used to perform comparisons between the three 
groups in several measurements. Other comparisons 
were made between the three groups using Chi-square, 
ANOVA and Kruskal-Wallis tests. The level of 
significance in all tests was less than and equal to 0.05. 
 
Results 
Of the 119 patients who were candidates for 
general anesthesia, 40 ones were assigned to the 
control group, 40 patients in the labetalol group, and 
39 in the dexmedetomidine group. It should be noted 
that 63 patients (52%) were male and 57 (47%) were 
female. The mean age of the subjects was 42.62±1.40 
years old (18-60 years old). 
According to Table 1, the demographic 
variables did not differ significantly between the three 
groups (p>0.05). (Table1) 
Results revealed significant difference in the 
MAP, SBP and DBP (P=0.00).However, the difference 
between the three groups for the HR, SpO2, Full 
Consciousness and Recovery duration variable was not 
statistically significant (p>0.05) (Table 2). 
 
Discussion 
Tracheal intubation is a process that is 
performed before surgery for oxygenation, and without 
it, performing the most surgeries under general 
anesthesia will be impossible in practice. On the other 
Table 1: Comparison of variables and demographic characteristics of patients in the groups. 
Variables  Control (N=40) Labetalol (N=40) Dexmedetomidine (N=39) p 
Age (yrs.) 42.85 ± 2.83 45.88 ± 2.31 39.69 ± 2.01 0.14 
Weight (kg) 75.27 ± 1.73 71.05 ± 1.73 73 ± 1.43 0.47 
Height (cm) 169.05 ± 1.33 
 
168.91 ± 1.11 170.41 ± 1.02 0.54 
Gender(%)n F (42.5%) 17 F (60%) 24 F (37%) 15 0.17 
 M (55%) 22 M(40%) 16 M(62.5%) 25 
F, Female; M, Male. 
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hand, various studies and experiments have shown that 
intubation is associated with the occurrence of some 
hemodynamic disorders, including increased or 
decreased blood pressure and heart rate in the patient, 
which if not taken by the anesthesia specialist, can have 
harmful consequences and even lead to the patient's 
death. 
In this regard, labetalol and dexmedetomidine 
are among the drugs that are currently widely used to 
maintain hemodynamic stability in patients undergoing 
various surgeries. Since there exists a dearth of studies 
on the effect of these two drugs, this study sought to 
determine the effect of prescribing labetalol and 
dexmedetomidine on changes in blood pressure and 
heart rate after laryngoscopy and tracheal intubation as 
compared to the control group. 
According to the results of this study, there were 
no significant differences between the three groups 
receiving labetalol, dexmedetomidine and control in 
terms of demographic and basic variables. In the 
analyses, there was no detectable effect. Hence, the 
differences observed between the three groups are 
likely to be related to the type of drug used. The 
evaluation of hemodynamic parameters showed that 
during the study period, mean arterial blood pressure, 
systolic blood pressure, diastolic blood pressure and 
hemoglobin saturation were not observed. However, 
the difference between the three groups for the heart 
rate variable was statistically significant. Results of 
post hoc test showed that heart rate in the 
dexmedetomidine group was significantly less than 
that in labetalol group and control group. However, 
contrary to the results of the present study, in the study 
by Chung et al., the mean dose of labetalol blouse was 
associated with suppression of heart rate response to 
laryngoscopy and intubation, but had the slightest 
effect on hypertension (5). 
In addition, time was considered as an effective 
factor in changing the mean arterial blood pressure, 
systolic blood pressure, diastolic blood pressure, 
hemoglobin saturation and heart rate. Interaction 
analysis also showed that the mean changes in mean 
arterial blood pressure, systolic blood pressure, 
diastolic blood pressure, hemoglobin saturation and 
heart rate varied in three groups over time. 
In a study by Singh et al., 40 patients were 
divided into 4 groups of 10, each of whom received 
placebo (normal saline), 100 mg lidocaine, 5 mg 
labetalol and 10 mg labetalol in the two minutes before 
laryngoscopy and received a tracheal intubation as an 
intravenous blouse before the induction of anesthesia. 
The results showed that injection of 10 mg of labetalol 
inhibited cardiac pacing, and had a lower heart rate 
compared to those who received placebo or lidocaine 
or 5 mg labetalol after laryngoscopy, but the response 
to blood pressure in the four groups was not 
significantly different. In this study, it was concluded 
that administration of 10 mg intravenous labetalol 








SBP mmHg 144.17 ± 3.60 
 
130.77 ± 2.47 122.07 ± 2.89 0.00 
DBP mmHg 92.35 ± 2.25 
 
84.77 ± 2.18 77.70 ± 2.21 
 
0.00 
MAP mmHg 109.92 ± 2.81 
 
101.95 ± 2.36 92.37 ± 2.33 
 
0.00 
HR beat/Min 87.32 ± 2.41 
 
83.37 ± 2.46 
 
80.65 ± 1.53 0.09 
SpO2 (%) 97.12 ± 0.11 
 
97.23 ± 0.14 
 
96.75 ± 0.20 0.11 
Full consciousness  Min 67.54 ± 6.90 
 
77.71 ± 6.69 73.66 ± 6.21 0.41 
Recovery duration Min 108.64 ± 
10.87 
114.34 ±11.87 109.09 ±9.79 0.99 
SBP, Systolic blood pressure; DBP, Diastolic blood pressure; MAP, Mean arterial pressure; HR, Heart rate;SpO2, saturation of 
peripheral oxygen. 
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before the induction of anesthesia was a safe and cost 
effective means to prevent increase in heart rate, but in 
preventing an increase in blood pressure in response to 
laryngoscopy and intubation, it was not effective (4). 
Conclusion 
With regard to the results of the study 
demonstrated that using labetalol provided more 
hemodynamic laryngoscopy and lower incidence of 
hemodynamic disorders is suggested in comparison 
with labetalol. 
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